Open AccessSafety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study
Author(s) -
Kathleen Squires,
LindaGail Bekker,
Joseph J. Eron,
Benjamin S. Cheng,
Juergen Rockstroh,
Farid Marquez,
Princy Kumar,
Melanie Thompson,
Rafael Campo,
Karam Mounzer,
Kim M. Strohmaier,
Chengxing Lu,
Anthony Rodgers,
Beth E. Jackson,
Larissa Wenning,
Michael J. Robertson,
Bach Nguyen,
Peter Sklar
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/erbm-f902
Subject(s) - raltegravir , tolerability , medicine , human immunodeficiency virus (hiv) , cohort , pharmacology , virology , antiretroviral therapy , adverse effect , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom